Acrow Confirms First Half 2026 Guidance Range
| Stock | Acrow Ltd (ACF.ASX) |
|---|---|
| Release Time | 17 Feb 2026, 9:03 a.m. |
| Price Sensitive | Yes |
Acrow Confirms First Half 2026 Guidance Range
- Confirm 1H FY26 revenue and EBITDA guidance range
- Industrial Access division on track to deliver $200 million full year revenue
- Strong growth in SA and WA formwork markets
- Queensland general formwork market showing signs of Q4 FY26 uptick
- Screens and Jumpform capital expenditure brought forward to meet strong forward order book
Acrow Limited (ASX: ACF) has provided a trading update on its financial performance for the six months ended 31 December 2025. Based on current trading conditions, the Company is pleased to confirm, on an un-audited basis, that the 1H FY26 results will be in-line with the guidance range provided at the Annual General Meeting (AGM) on 14 November 2025. Under the new segment reporting framework, the Industrial Access division continues to experience buoyant market conditions, with recent acquisitions performing in-line with expectations. The division remains well positioned to deliver annual revenue approaching $200 million in FY26. While the medium to longer-term outlook for the Construction division remains very positive, the Queensland general formwork market continues to experience project delays in the near term, resulting in subdued trading conditions. However, activity levels are now showing tangible signs of an uptick into Q4 FY26. The pipeline remains robust and current results in the SA and WA markets are at record levels. The forward order book for both the Screens and Jumpform divisions is at unprecedented levels across the country. To ensure the Company is positioned to service the forward order book as well as the expected contract wins over the next few months, equipment purchases have been brought forward into the first half of the financial year. Accordingly, capital expenditure in 1H FY26 is expected to be approximately $25 million, with total FY26 capital expenditure anticipated to be in the range of $30 million to $36 million.
Metric (underlying) 1H FY26 guidance: Sales $153.0m - $157.0m (+22% on PCP), EBITDA $37.0m - $40.0m (-1% on PCP)